BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32900774)

  • 1. YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice.
    Park J; Eisenbarth D; Choi W; Kim H; Choi C; Lee D; Lim DS
    Cancer Res; 2020 Nov; 80(21):4768-4779. PubMed ID: 32900774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis.
    Morvaridi S; Dhall D; Greene MI; Pandol SJ; Wang Q
    Sci Rep; 2015 Nov; 5():16759. PubMed ID: 26567630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
    Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
    Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.
    Zhang W; Nandakumar N; Shi Y; Manzano M; Smith A; Graham G; Gupta S; Vietsch EE; Laughlin SZ; Wadhwa M; Chetram M; Joshi M; Wang F; Kallakury B; Toretsky J; Wellstein A; Yi C
    Sci Signal; 2014 May; 7(324):ra42. PubMed ID: 24803537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
    Gopal U; Mowery Y; Young K; Pizzo SV
    J Biol Chem; 2019 Sep; 294(38):13939-13952. PubMed ID: 31358620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth.
    Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL
    Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway.
    Fukunaga Y; Fukuda A; Omatsu M; Namikawa M; Sono M; Masuda T; Araki O; Nagao M; Yoshikawa T; Ogawa S; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Ferrer J; Tsuruyama T; Masui T; Hatano E; Seno H
    Gastroenterology; 2022 Aug; 163(2):466-480.e6. PubMed ID: 35483445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.
    Santoro R; Zanotto M; Simionato F; Zecchetto C; Merz V; Cavallini C; Piro G; Sabbadini F; Boschi F; Scarpa A; Melisi D
    Mol Cancer Ther; 2020 Jan; 19(1):247-257. PubMed ID: 31562256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.
    Murakami S; Shahbazian D; Surana R; Zhang W; Chen H; Graham GT; White SM; Weiner LM; Yi C
    Oncogene; 2017 Mar; 36(9):1232-1244. PubMed ID: 27546622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma.
    Hayashi H; Uemura N; Zhao L; Matsumura K; Sato H; Shiraishi Y; Baba H
    Front Oncol; 2021; 11():700315. PubMed ID: 34395269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression.
    Li H; Li Q; Dang K; Ma S; Cotton JL; Yang S; Zhu LJ; Deng AC; Ip YT; Johnson RL; Wu X; Punzo C; Mao J
    Cell Rep; 2019 Dec; 29(10):3200-3211.e4. PubMed ID: 31801083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.
    Murakami S; Nemazanyy I; White SM; Chen H; Nguyen CDK; Graham GT; Saur D; Pende M; Yi C
    Dev Cell; 2019 Oct; 51(1):113-128.e9. PubMed ID: 31447265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth.
    Strnadel J; Choi S; Fujimura K; Wang H; Zhang W; Wyse M; Wright T; Gross E; Peinado C; Park HW; Bui J; Kelber J; Bouvet M; Guan KL; Klemke RL
    Cancer Res; 2017 Apr; 77(8):1997-2007. PubMed ID: 28381547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma.
    Zhao C; Gong J; Bai Y; Yin T; Zhou M; Pan S; Liu Y; Gao Y; Zhang Z; Shi Y; Zhu F; Zhang H; Wang M; Qin R
    Cell Death Differ; 2023 Jan; 30(1):1-15. PubMed ID: 35906484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
    Hao F; Xu Q; Wang J; Yu S; Chang HH; Sinnett-Smith J; Eibl G; Rozengurt E
    PLoS One; 2019; 14(5):e0216603. PubMed ID: 31100067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.
    Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G
    Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yap/Taz promote the scavenging of extracellular nutrients through macropinocytosis.
    King B; Araki J; Palm W; Thompson CB
    Genes Dev; 2020 Oct; 34(19-20):1345-1358. PubMed ID: 32912902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.
    Eibl G; Rozengurt E
    Semin Cancer Biol; 2019 Feb; 54():50-62. PubMed ID: 29079305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.